CADL vs FAST · $592.0M cap vs P/E 43, rev $4.59B
Candel Therapeutics Inc (CADL) versus Fastenal Company (FAST) — a side-by-side from cached financials, not a winner call.
Candel Therapeutics Inc (CADL) is a biotechnology company listed on NASDAQ.
Fastenal Company (FAST) is a industrial distribution company listed on US.
CADL does not have a complete income-statement cache yet.
Latest reported FAST revenue for 2026-06-30 was $4.59B. Net income was $722.6M. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
CADL currently screens at market cap $592.0M. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
Not investment advice. Open the CADL and FAST stock pages for the full models.
Not investment advice.